Spero Therapeutics
SPRO
#9017
Rank
โ‚ฌ0.10 B
Marketcap
1,94ย โ‚ฌ
Share price
-0.88%
Change (1 day)
77.14%
Change (1 year)

Spero Therapeutics (SPRO) Fails to deliver data

Key failure to deliver metrics for Spero Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spero Therapeutics (SPRO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Spero Therapeutics (SPRO) - since 2017

Volume in USD (price x number of shares), data since 2017

Spero Therapeutics (SPRO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ6.13 M1062.49%
2024โ‚ฌ0.52 M-38.44%
2023โ‚ฌ0.85 M-88.65%
2022โ‚ฌ7.55 M81.02%
2021โ‚ฌ4.17 M23.57%
2020โ‚ฌ3.37 M2331.08%
2019โ‚ฌ0.13 M-93.38%
2018โ‚ฌ2.09 M-76.81%
2017โ‚ฌ9.04 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Franklin Covey
FC
โ‚ฌ0.17 Mโ‚ฌ3.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
IBM
IBM
โ‚ฌ0.30 Bโ‚ฌ0.65 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
โ‚ฌ0.11 Bโ‚ฌ0.46 B๐Ÿ‡จ๐Ÿ‡ฆ Canada